The ETS1 has been shown to be a driving factor for the progression of majority cancers (Dittmer, 2015; Chen et al., 2019) and its down-regulation inhibits the progression of colorectal cancer (Gu et al., 2019). This evidence concerns the gene ETS1 and cancer.